Acetylsalicylic Acid
Cerebral Small Vessel Disease
First Affiliated Hospital of Chengdu Medical CollegePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
1 Active assets in the Cerebral Small Vessel Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Plavix First Affiliated Hospital of Chengdu Medical College | Phase 4 | BB |
Same molecule, other indications
Acetylsalicylic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →